INSIGHTS ON CELL & GENE CLINICAL TRIALS
-
![Doctor-researching the internet GettyImages-1413603540]( "De-Risking Cell And Gene Therapy Clinical Trials")
De-Risking Cell And Gene Therapy Clinical TrialsOhio State University Gene Therapy Institute's Dr. Russell Lonser explains five major reasons for the early failures in direct delivery gene therapy trials, methods and technologies to increase the efficacy of direct drug delivery, and more.
-
![GettyImages-597935610 cell and gene]( "In Silico Modeling Unveils A New Era In Rare Disease Drug Development")
In Silico Modeling Unveils A New Era In Rare Disease Drug DevelopmentGain insights into how innovative silico modeling is revolutionizing rare disease drug development and opening new possibilities for accelerated research.
-
![GettyImages-1136666580 checklist]( "Evaluating A CRO For Rare Disease Studies: A Checklist For Success")
Evaluating A CRO For Rare Disease Studies: A Checklist For SuccessWhen launching an RFP, refer to this checklist to ensure comprehensive coverage of all aspects when evaluating potential research partners for the rare disease study.
-
![GettyImages-655801842 data]( "Early Planning To De-Risk Development: Strategy & Study Design")
Early Planning To De-Risk Development: Strategy & Study DesignAccess insightful guides and checklists that provide valuable advice and best practices for planning and executing effective nonclinical studies.
-
![GettyImages-1445640967 RNA therapy]( "RNA Therapies – Global Clinical Trial Landscape - Focus On Asia Pacific")
RNA Therapies – Global Clinical Trial Landscape - Focus On Asia PacificLearn about the global clinical trial landscape of RNA therapy, with emphasis on trends in the Asia Pacific, and recent advancements in the field.
-
![Treatment Adjustment DNA GettyImages-1404251307]( "The Potential Of Prime Editing")
The Potential Of Prime EditingAnn L. Lee, Ph.D., Chief Technical Officer at Prime Medicine explains prime editing’s potential to make wholesale changes to DNA at one time.
-
![GettyImages-1387090964 cell and gene therapy]( "The Cell & Gene Therapy Clinical Trials Global Landscape")
The Cell & Gene Therapy Clinical Trials Global LandscapeGain valuable insights into the current state of cell and gene therapy clinical trials and the opportunities and challenges in this rapidly evolving field.
-
![GettyImages-1441979374 clinical team]( "What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan?")
What Are The Benefits Of A Well-Designed, Robust Preclinical Development Plan?Discover how a well-designed and robust preclinical development plan can help identify potential safety and efficacy issues early in the drug development process, ultimately reducing the risk of failure in clinical trials.
-
![GettyImages-1293772957 clinical trials]( "Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific")
Phase I Trials Global Clinical Trial Landscape – Focus On Asia PacificDiscover key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in the last five-year period in popular trial regions of Asia Pacific, the United States, and Europe.
-
![GettyImages-1358868801 antibodies]( "Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia Pacific")
Multi-Specific Monoclonal Antibodies – Global Clinical Trial Landscape - Focus On Asia PacificLearn about the global clinical trial landscape of multi-specific monoclonal antibodies (Mabs), with emphasis on trends in the Asia Pacific, and recent advancements in the field.
